中国乙型肝炎病毒母婴传播防治指南(2019年版)

2019-07-30 中华医学会感染病学会分会 中华传染病杂志.2019.37(7):388-396.

阻断母婴传播是消除乙型肝炎病毒(HBV)感染的关键环节。由中华医学会感染病学分会发起,联合多学科专家,基于系统评价证据,结合患者意愿,采用评估、制订和评价(GRADE)分级,遵循RIGHT 报告标准,制订我国首部循证HBV 母婴传播防治指南,以期为临床医师和妇幼保健相关人员提供围产期监测、干预和新生儿免疫的决策依据。

中文标题:

中国乙型肝炎病毒母婴传播防治指南(2019年版)

发布日期:

2019-07-30

简要介绍:

阻断母婴传播是消除乙型肝炎病毒(HBV)感染的关键环节。由中华医学会感染病学分会发起,联合多学科专家,基于系统评价证据,结合患者意愿,采用评估、制订和评价(GRADE)分级,遵循RIGHT 报告标准,制订我国首部循证HBV 母婴传播防治指南,以期为临床医师和妇幼保健相关人员提供围产期监测、干预和新生儿免疫的决策依据。

 

拓展指南:乙肝相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222437, encodeId=9e67122243e15, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:35:27 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925818, encodeId=344f92581804, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b42201187, createdName=120b5a82m90(暂无昵称), createdTime=Sat Feb 20 14:05:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810293, encodeId=b4da8102934c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/3a2a41c558f84a7d8dec1b64044cfa2e/6ca0c9def58f4ce3b584a361ac08c2c2.jpg, createdBy=0b6b5321111, createdName=148ab3bam40暂无昵称, createdTime=Tue Aug 18 12:57:45 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2022-05-25 自此烟雨落盛京

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222437, encodeId=9e67122243e15, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:35:27 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925818, encodeId=344f92581804, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b42201187, createdName=120b5a82m90(暂无昵称), createdTime=Sat Feb 20 14:05:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810293, encodeId=b4da8102934c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/3a2a41c558f84a7d8dec1b64044cfa2e/6ca0c9def58f4ce3b584a361ac08c2c2.jpg, createdBy=0b6b5321111, createdName=148ab3bam40暂无昵称, createdTime=Tue Aug 18 12:57:45 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2021-02-20 120b5a82m90(暂无昵称)

    获益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222437, encodeId=9e67122243e15, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16895728910, createdName=自此烟雨落盛京, createdTime=Wed May 25 21:35:27 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925818, encodeId=344f92581804, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38b42201187, createdName=120b5a82m90(暂无昵称), createdTime=Sat Feb 20 14:05:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=810293, encodeId=b4da8102934c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200818/3a2a41c558f84a7d8dec1b64044cfa2e/6ca0c9def58f4ce3b584a361ac08c2c2.jpg, createdBy=0b6b5321111, createdName=148ab3bam40暂无昵称, createdTime=Tue Aug 18 12:57:45 CST 2020, time=2020-08-18, status=1, ipAttribution=)]
    2020-08-18 148ab3bam40暂无昵称

    值得学习

    0